HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gaubatz, J. W. Articles by Morrisett, J. D. Search for Related Content PubMed PubMed Citation Articles by Gaubatz, J. W. Articles by Morrisett, J. D. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 28, 69-79, Copyright © 1987 by Lipid Research, Inc.

ARTICLES

Isolation and characterization of the two major apoproteins in human lipoprotein [a]

JW Gaubatz, MV Chari, ML Nava, JR Guyton and JD Morrisett

Human Lp[a] was isolated in preparative amounts from two donors; the native lipoprotein and its constituent apoproteins, apo[a] and apoB, were characterized extensively. Based on differences in apparent molecular weight, four different isoforms of apo[a], a1-a4, were observed between the two donors. The number and relative distribution of these isoforms varied between donors but were constant for each donor. Each apo[a] isoform was shown to be derived from a discrete apo[a]-B100 disulfide-linked complex present before reduction. Complete delipidation of Lp[a] was followed by solubilization, reduction, and carboxamidomethylation of the constituent apoproteins. These apoproteins were then separated by immunoaffinity chromatography using anti-apo[a]- or anti-apoB-Sepharose; their purity and structural integrity were demonstrated by Western blot analysis. ApoB isolated by this procedure was essentially identical to apoB from autologous LDL with respect to molecular weight, secondary structure, amino acid composition, and sialic acid content. However, apo[a] differed from apoB in that it exhibited: a much less alpha-helical, less beta, but much more disordered structure; a lower proportion of aspartate, isoleucine, leucine, phenylalanine, and lysine, but a higher proportion of proline, glycine, and threonine; and a much higher content of sialic acid. These results indicate that apo[a] is not a superglycosylated form of apoB but is distinctly different in its composition and structure.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Ohira, P. J. Schreiner, J. D. Morrisett, L. E. Chambless, W. D. Rosamond, and A. R. Folsom Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study Stroke, June 1, 2006; 37(6): 1407 - 1412. [Abstract] [Full Text] [PDF]

				L. E. Chambless, G. Heiss, E. Shahar, M. J. Earp, and J. Toole Prediction of Ischemic Stroke Risk in the Atherosclerosis Risk in Communities Study Am. J. Epidemiol., August 1, 2004; 160(3): 259 - 269. [Abstract] [Full Text] [PDF]

				N. S. Haque, J. T. Fallon, J. J. Pan, M. B. Taubman, and P. C. Harpel Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion Blood, February 15, 2004; 103(4): 1296 - 1304. [Abstract] [Full Text] [PDF]

				A. W. Tsai, M. Cushman, W. D. Rosamond, S. R. Heckbert, J. F. Polak, and A. R. Folsom Cardiovascular Risk Factors and Venous Thromboembolism Incidence: The Longitudinal Investigation of Thromboembolism Etiology Arch Intern Med, May 27, 2002; 162(10): 1182 - 1189. [Abstract] [Full Text] [PDF]

				L. E. Chambless, A. R. Folsom, V. Davis, R. Sharrett, G. Heiss, P. Sorlie, M. Szklo, G. Howard, and G. W. Evans Risk Factors for Progression of Common Carotid Atherosclerosis: The Atherosclerosis Risk in Communities Study, 1987-1998 Am. J. Epidemiol., January 1, 2002; 155(1): 38 - 47. [Abstract] [Full Text] [PDF]

				N. S. Haque, J. T. Fallon, M. B. Taubman, and P. C. Harpel The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium Blood, January 1, 2001; 97(1): 39 - 45. [Abstract] [Full Text] [PDF]

				N. S. Haque, X. Zhang, D. L. French, J. Li, M. Poon, J. T. Fallon, B. R. Gabel, M. B. Taubman, M. Koschinsky, and P. C. Harpel CC Chemokine I-309 Is the Principal Monocyte Chemoattractant Induced by Apolipoprotein(a) in Human Vascular Endothelial Cells Circulation, August 15, 2000; 102(7): 786 - 792. [Abstract] [Full Text] [PDF]

				D. K. Bonen, F. Nassir, A. M. L. Hausman, and N. O. Davidson Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro J. Lipid Res., August 1, 1998; 39(8): 1629 - 1640. [Abstract] [Full Text]

				M. Poon, X. Zhang, K. G. Dunsky, M. B. Taubman, and P. C. Harpel Apolipoprotein(a) Induces Monocyte Chemotactic Activity in Human Vascular Endothelial Cells Circulation, October 21, 1997; 96(8): 2514 - 2519. [Abstract] [Full Text]

				F. J. Nieto, P. Sorlie, G. W. Comstock, K. Wu, E. Adam, J. L. Melnick, and M. Szklo Cytomegalovirus Infection, Lipoprotein(a), and Hypercoagulability: An Atherogenic Link? Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1780 - 1785. [Abstract] [Full Text]

				A. Gries, M. Gries, H. Wurm, T. Kenner, M. Ijsseldijk, J. J. Sixma, and G. M. Kostner Lipoprotein(a) Inhibits Collagen-Induced Aggregation of Thrombocytes Arterioscler. Thromb. Vasc. Biol., May 1, 1996; 16(5): 648 - 655. [Abstract] [Full Text]

				P. J. Schreiner, G. Heiss, H.A. Tyroler, J. D. Morrisett, C.E. Davis, and R. Smith Race and Gender Differences in the Association of Lp(a) With Carotid Artery Wall Thickness : The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 471 - 478. [Abstract] [Full Text]